Current Cancer Drug Targets logo Bentham Science Publishers logo

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 1, Number 3, November 2001

< previous issue | all issues | next issue >

Book Reviews

Preface
pp. i-i(1)
Author: Zhang, R.

Reviews

Antisense Anticancer Oligonucleotide Therapeutics
pp. 177-196(20)
Authors: Wang, H.; Prasad, G.; Buolamwini, J.K.; Zhang, R.

Antisense and / or Immunostimulatory Oligonucleotide Therapeutics
pp. 197-209(13)
Authors: Agrawal, S.; Kandimalla, E.R.

Targeting of Cancer-Related Proteins with PNA Oligomers
pp. 231-239(9)
Authors: Pooga, M.; Langel, U.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page